SANDS LAB Inc. (KOSDAQ:411080)

SANDS LAB Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Revenue	11,612	8,297
Revenue Growth (YoY)	39.96%	-
Gross Profit	11,612	8,297
Selling, General & Admin	10,225	9,744
Research & Development	2,021	1,522
Amortization of Goodwill & Intangibles	134.11	83.18
Operating Expenses	13,382	12,006
Operating Income	-1,770	-3,709
Interest Expense	-0.35	-9.34
Interest & Investment Income	1,012	1,371
Other Non Operating Income (Expenses)	-64.48	-52.32
EBT Excluding Unusual Items	-822.94	-2,399
Gain (Loss) on Sale of Investments	783.03	-390.6
Gain (Loss) on Sale of Assets	2.89	2.56
Pretax Income	-37.02	-2,787
Income Tax Expense	428.44	-486.95
Earnings From Continuing Operations	-465.47	-2,301
Minority Interest in Earnings	-84.18	-
Net Income	-549.64	-2,301
Net Income to Common	-549.64	-2,301
Shares Outstanding (Basic)	15	14
Shares Outstanding (Diluted)	15	14
Shares Change (YoY)	7.51%	-
EPS (Basic)	-36.00	-162.00
EPS (Diluted)	-36.00	-162.00
Free Cash Flow	-269.9	-5,815
Free Cash Flow Per Share	-17.68	-409.47
Gross Margin	100.00%	100.00%
Operating Margin	-15.25%	-44.70%
Profit Margin	-4.73%	-27.73%
Free Cash Flow Margin	-2.32%	-70.08%
EBITDA	-632.81	-2,918
EBITDA Margin	-5.45%	-35.17%
D&A For EBITDA	1,138	791.1
EBIT	-1,770	-3,709
EBIT Margin	-15.25%	-44.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.